tiprankstipranks
Cannara Biotech (LOVFF)
OTHER OTC:LOVFF

Cannara Biotech (LOVFF) Financial Statements

8 Followers

Cannara Biotech Financial Overview

Cannara Biotech's market cap is currently ―. The company's EPS TTM is $0.075; its P/E ratio is 8.05; Cannara Biotech is scheduled to report earnings on April 24, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 23Aug 23May 23Feb 23Nov 22
Income Statement-
Total RevenueC$ 19.48MC$ 18.28MC$ 15.94MC$ 13.04MC$ 10.31M
Gross ProfitC$ 7.94MC$ 6.89MC$ 6.12MC$ 4.03MC$ 4.83M
EBITC$ 3.49MC$ 6.55MC$ 4.31MC$ 351.02KC$ 866.86K
EBITDAC$ 5.11MC$ 7.87MC$ 5.59MC$ 1.53MC$ 2.03M
Net Income Common StockholdersC$ 2.11MC$ 4.63MC$ 2.93MC$ -618.05KC$ 2.95K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 2.64MC$ 4.27MC$ 4.03MC$ 4.14MC$ 6.76M
Total AssetsC$ 144.82MC$ 141.52MC$ 135.37MC$ 129.15MC$ 125.43M
Total DebtC$ 42.15MC$ 41.78MC$ 44.54MC$ 43.36MC$ 48.20M
Net DebtC$ 39.52MC$ 37.51MC$ 40.52MC$ 39.22MC$ 41.44M
Total LiabilitiesC$ 62.96MC$ 61.78MC$ 60.40MC$ 57.37MC$ 58.14M
Stockholders EquityC$ 81.86MC$ 79.74MC$ 74.98MC$ 71.77MC$ 67.28M
Cash Flow-
Free Cash FlowC$ -2.41MC$ 1.18MC$ -43.86KC$ -1.26MC$ -4.14M
Operating Cash FlowC$ 354.22KC$ 2.84MC$ 2.53MC$ 376.96KC$ -315.09K
Investing Cash FlowC$ -2.73MC$ -1.63MC$ -2.54MC$ -1.57MC$ -3.74M
Financing Cash FlowC$ 747.32KC$ -973.30KC$ -107.64KC$ -1.41MC$ -1.23M
Currency in CAD

Cannara Biotech Earnings and Revenue History

Cannara Biotech Debt to Assets

Cannara Biotech Cash Flow

Cannara Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis